BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

461 related articles for article (PubMed ID: 16034477)

  • 1. Does prophylactic phototherapy prevent hyperbilirubinemia in neonates with ABO incompatibility and positive Coombs' test?
    Yaseen H; Khalaf M; Rashid N; Darwich M
    J Perinatol; 2005 Sep; 25(9):590-4. PubMed ID: 16034477
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Morbidity of ABO haemolytic disease in the newborn.
    Bhat YR; Kumar CG
    Paediatr Int Child Health; 2012 May; 32(2):93-6. PubMed ID: 22595217
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Significance of anti-A and anti-B isohemagglutinins in cord blood of ABO incompatible newborn infants: correlation with hyperbilirubinemia.
    Serrao PA; Modanlou HD
    J Perinatol; 1989 Jun; 9(2):154-8. PubMed ID: 2738726
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rebound hyperbilirubinemia in term infants after phototherapy.
    Al-Saedi SA
    Saudi Med J; 2002 Nov; 23(11):1394-7. PubMed ID: 12506303
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intravenous immunoglobulin G (IVIG) therapy for significant hyperbilirubinemia in ABO hemolytic disease of the newborn.
    Miqdad AM; Abdelbasit OB; Shaheed MM; Seidahmed MZ; Abomelha AM; Arcala OP
    J Matern Fetal Neonatal Med; 2004 Sep; 16(3):163-6. PubMed ID: 15590442
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prediction of the development of neonatal hyperbilirubinemia in ABO incompatibility.
    Chen JY; Ling UP
    Zhonghua Yi Xue Za Zhi (Taipei); 1994 Jan; 53(1):13-8. PubMed ID: 8173995
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Value of the Coombs test in ABO incompatibility].
    Bel Comos J; Ribera Crusafont A; Natal Pujol A; Coroleu Lletget W; Pujol Posch N; Prats Viñas J
    An Esp Pediatr; 1991 Oct; 35(4):248-50. PubMed ID: 1763851
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identifying ABO incompatibility in newborns: selective vs automatic testing.
    Madlon-Kay DJ
    J Fam Pract; 1992 Sep; 35(3):278-80. PubMed ID: 1517724
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [ABO hemolytic disease and developing of significant hyperbilirubinemia in term newborns: early predictive factors].
    Covas Mdel C; Medina MS; Ventura S; Gamero D; Giuliano A; Esandi ME; Alda E
    Arch Argent Pediatr; 2009 Feb; 107(1):16-25. PubMed ID: 19350139
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Yield of recommended blood tests for neonates requiring phototherapy for hyperbilirubinemia.
    Besser I; Perry ZH; Mesner O; Zmora E; Toker A
    Isr Med Assoc J; 2010 Apr; 12(4):220-4. PubMed ID: 20803881
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intravenous immunoglobulin in ABO and Rh hemolytic diseases of newborn.
    Nasseri F; Mamouri GA; Babaei H
    Saudi Med J; 2006 Dec; 27(12):1827-30. PubMed ID: 17143357
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Failure to predict hemolysis and hyperbilirubinemia by IgG subclass in blood group A or B infants born to group O mothers.
    Kaplan M; Na'amad M; Kenan A; Rudensky B; Hammerman C; Vreman HJ; Wong RJ; Stevenson DK
    Pediatrics; 2009 Jan; 123(1):e132-7. PubMed ID: 19114458
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of oral phenobarbitone in term "at risk" neonates in decreasing neonatal hyperbilirubinemia: a randomized double-blinded, placebo controlled trial.
    Arya VB; Agarwal R; Paul VK; Deorari AK
    Indian Pediatr; 2004 Apr; 41(4):327-32. PubMed ID: 15123861
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A chromosomal-effect study of intensive phototherapy versus conventional phototherapy in newborns with jaundice.
    Karadag A; Yesilyurt A; Unal S; Keskin I; Demirin H; Uras N; Dilmen U; Tatli MM
    Mutat Res; 2009 May; 676(1-2):17-20. PubMed ID: 19376266
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predischarge screening for severe neonatal hyperbilirubinemia identifies infants who need phototherapy.
    Bhutani VK; Stark AR; Lazzeroni LC; Poland R; Gourley GR; Kazmierczak S; Meloy L; Burgos AE; Hall JY; Stevenson DK;
    J Pediatr; 2013 Mar; 162(3):477-482.e1. PubMed ID: 23043681
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Double phototherapy in jaundiced term infants with hemolysis.
    Thaithumyanon P; Visutiratmanee C
    J Med Assoc Thai; 2002 Nov; 85(11):1176-81. PubMed ID: 12546314
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hour-specific bilirubin nomogram in infants with ABO incompatibility and direct Coombs-positive results.
    Schutzman DL; Sekhon R; Hundalani S
    Arch Pediatr Adolesc Med; 2010 Dec; 164(12):1158-64. PubMed ID: 21135346
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predictive value of cord blood bilirubin for hyperbilirubinemia in neonates at risk for maternal-fetal blood group incompatibility and hemolytic disease of the newborn.
    Calkins K; Roy D; Molchan L; Bradley L; Grogan T; Elashoff D; Walker V
    J Neonatal Perinatal Med; 2015; 8(3):243-50. PubMed ID: 26518407
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Outcome and cost analysis of implementing selective Coombs testing in the newborn nursery.
    Shahid R; Graba S
    J Perinatol; 2012 Dec; 32(12):966-9. PubMed ID: 22441112
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Positive Direct Antiglobulin Test: Is It a Risk Factor for Significant Hyperbilirubinemia in Neonates with ABO Incompatibility?
    Ercin S; Coskun Y; Kayas K; Kavas N; Gursoy T
    Am J Perinatol; 2024 Mar; 41(4):505-510. PubMed ID: 34847590
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.